Elizabeth Spencer, MD, explains the role of esophageal dilation in treatment of eosinophilic esophagitis (EoE), highlighting the importance of shared decision-making.
This is a video synopsis/summary of an Insights involving Elizabeth Spencer, MD.
Spencer discusses endoscopic dilation therapy for eosinophilic esophagitis (EoE). She explains dilation expands the strictured or scarred areas of the esophagus, allowing food to pass without getting stuck. Dilation is very effective and safe with an extremely low risk of esophageal perforation. The goal of EoE treatment is to intervene early enough to prevent strictures and the need for dilation. However, when necessary, dilation is a good option.
There is no one-size-fits-all approach for EoE. Spencer utilizes shared decision-making to determine the best individualized treatment plan based on patient priorities and feasibility. For example, some patients refuse dietary elimination therapy. Then medical options would be considered instead like proton pump inhibitors or the recently approved monoclonal antibody therapy dupilumab. Shared decision-making leads to better adherence, trust in the provider, and patient engagement. Treatment plans involve ongoing discussions and are not static.
Video synopsis is AI-generated and reviewed by AJMC® editorial staff.